Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia

NCT01556685 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT01556685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01556685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia
Lead sponsor
Biogen
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2011
Completion date
Not reported
Enrollment
180 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis